Overview :

• India grows 50% of the world's guar. It is the world's largest producer of spices. It exports cotton to global textile supply chains and feeds 1.4 billion people on pulses that no other futures market in the world prices efficiently. One exchange sits at the centre of all of this: NCDEX, which controls 97% of India's agri-commodity derivatives market and operates the only standardised futures and options contracts in crops ranging from jeera and dhaniya to turmeric, guar seed, and yellow peas.

• National Commodity & Derivatives Exchange Limited, incorporated in April 2003 and operational since December 2003, is a SEBI-recognized national-level exchange. Revenue from operations was ₹90.44 crore in FY26, down from a peak driven by SEBI's suspension of key commodity contracts since December 2021, a ban that has been extended every year and now runs to March 2026. That single regulatory action suppressed 70% of NCDEX's volumes and turned a functioning exchange into a structurally loss-making one. Core operating losses have narrowed from ₹65 crore (pre-exceptional FY25) to ₹46 crore (FY26 post-tax), with ₹770 crore raised in September 2025 from Radhakishan Damani, Groww, Zerodha, Citadel Securities, Tower Research, and 57 other investors at ₹197.34 per share.

• SEBI granted in-principle approval in July 2025 for NCDEX to launch equity and equity derivatives trading. The exchange plans to go live in the equity cash segment by August 2026, followed by derivatives. The ₹770 crore raise, the institutional investor roster, and the SEBI nod together represent a pivot that, if it works, transforms NCDEX from a commodity niche player into India's fourth fully functioning multi-asset exchange. The current unlisted price of ₹368 per share, at a market cap of ₹3,301 crore, is the market's current probability-weighted estimate of that transformation.

• There is a specific type of exchange that no well-designed capital market ecosystem can afford to ignore: the one that prices the food that feeds the nation. Wheat, chana, mustard, guar, turmeric, cotton, soya bean — these are not financial abstractions. They are the raw inputs for India's food security, oilseed industry, textile supply chains, and rural income. The futures and options contracts that NCDEX provides are, for farmers, millers, traders, and agri-processors, the difference between hedged certainty and unhedged exposure. India's 97% concentration of agri-commodity derivatives in a single exchange reflects this: there is no meaningful second venue for price discovery in these markets.

• That structural dominance is the foundation of the NCDEX story. The complications come from the SEBI ban on key commodity contracts, the resulting revenue contraction, and now the strategic pivot toward equity markets using ₹770 crore of fresh institutional capital.

Origin : From NSE-NABARD Initiative to India's Agri Exchange

• NCDEX was incorporated as a public limited company on April 23, 2003, pursuant to a certificate of incorporation granted by the Registrar of Companies, Maharashtra at Mumbai. The Certificate for Commencement of Business was received on May 9, 2003. Commercial operations commenced on December 15, 2003, making NCDEX one of India's earliest dedicated commodity exchange platforms.

• The company's CIN is U51909MH2003PLC140116. Registered at Akruti Corporate Park, Kanjurmarg (West), Mumbai, NCDEX was promoted by a consortium of institutional shareholders including National Stock Exchange of India Limited, National Bank for Agriculture and Rural Development (NABARD), CRISIL (now S&P India), Life Insurance Corporation of India, and ICICI Bank. Current institutional shareholders include IFFCO, LIC, NABARD, Canara Bank, Punjab National Bank, NSE, and others. The exchange became a deemed recognized stock exchange under the Securities Contracts (Regulation) Act, 1956, in September 2015, giving it the same regulatory standing as India's equity exchanges.

• NCDEX operates from a Tier-IV data center, the first Indian exchange to do so, with Disaster Recovery and Near-Site infrastructure, ensuring operational readiness through periodically stress-tested live drills. The exchange's clearing and settlement subsidiary, National Commodity Clearing Limited (NCCL), is wholly owned and handles all clearing for NCDEX-listed commodity contracts.

• The MD & CEO is Arun Raste (DIN: 08561128), who signed off on the FY25 audited results approved by the Board on May 23, 2025. The CFO is Atul Roongta. The Company Secretary is Hoshi D. Bhagwagar. Chairman Ashish Bahuguna is a Public Interest Director, and the board includes additional Public Interest Directors: Soma Sankara Prasad, R. Amalorpavanathan, Dr. Mukulita Vijayawargiya, and Hemant Adarkar.

The Commodity Business : 97% Market Share, 23 Permitted Commodities, the Guar-to-Turmeric Franchise

• NCDEX trades 23 permitted agricultural commodities, the broadest basket among Indian exchanges. The portfolio spans: guar seed and guar gum (India grows 80% of the world's guar); turmeric, jeera (cumin), dhaniya (coriander), and other spices; pulses including chana and yellow peas; oilseeds including mustard seed and soya bean; and cotton wash oil. Many of these commodities are not traded on any meaningful global futures platform, making NCDEX the sole global price discovery venue for them.

• The exchange's offering includes commodity futures, options in goods, and index futures. In FY25, NCDEX added futures in Yellow Peas and Cotton Wash Oil, and launched options in Guar Seed, Guar Gum, Dhaniya, Jeera, and Turmeric. Average Daily Open Interest grew 10% in FY24 to ₹2,278 crore, and Average Daily Traded Value for continuing contracts (those not suspended) was ₹834 crore.

• The exchange subsidiary NCDEX e-Markets Limited (NeML) and the joint venture ReMS facilitate agri e-market platforms for spot and procurement market operations, connecting farmers directly to buyers, eliminating intermediaries, and extending NCDEX's reach into India's 6,500-plus regulated market yards. In FY25, ReMS also initiated warehouse-based sales. The National E-Repository Limited (NERL), a separately operating electronic warehouse receipt repository, had NCDEX as a shareholder. During FY25, NCDEX divested its excess 16.22% stake in NERL as required under regulatory guidelines. NCDEX also holds a 20% stake in Sri Lanka's first commodity exchange, following an MoU signed to develop commodity derivatives in the island nation.

The Commodity Ban : One Regulatory Decision That Changed Everything

• In December 2021, SEBI suspended futures trading in seven key commodities: paddy (non-basmati), wheat, chana, mustard seeds and its derivatives, soya bean and its derivatives, crude palm oil, and moong. The stated rationale was curbing speculation driving food price inflation. The ban was originally set for December 2022, extended to December 2023, then to December 2024, then to January 2025, then to March 2025, and in the latest extension, to March 31, 2026.

• The impact on NCDEX was structural. The suspended commodities collectively represented approximately 70% of the exchange's trading volumes. Revenue from operations declined from approximately ₹52.83 crore (standalone FY25) to lower levels, and on a consolidated basis total income fell from ₹136.06 crore (FY24) to ₹122.06 crore (FY25). The exchange shifted from operating profitability to consistent operating losses. FY22 and FY23 were loss years. FY24 was a loss year. FY25 showed a reported profit of ₹236.09 crore, but this was entirely driven by ₹344 crore in exceptional income from stake sales in PXIL and NERL. Normalized for those one-time gains, the FY25 core operating loss was approximately ₹65 crore.

• Every year the commodity ban is not lifted is a year of operating cash burn for NCDEX. But every year it is not lifted also means the market is starved of price discovery in India's most economically critical agri-commodities, and the case for lifting it grows stronger as inflation concerns moderate.

FY25 Financial Performance: Exceptional Gains Obscure the Reality

The following is based on the audited Consolidated Financial Results for the year ended March 31, 2025, approved by the Board on May 23, 2025, and published in Financial Express (all editions) and Navrashtra (Mumbai), May 24, 2025.

• Total income from operations was ₹122.06 crore, down 10.3% from ₹136.06 crore in FY24. Revenue from operations was ₹88.19 crore, with other income of ₹33.87 crore. The operating cost structure remained heavy: employee benefits ₹95.93 crore, technology ₹44.62 crore, D&A ₹25.09 crore, and other expenses ₹30.37 crore. Before exceptional items and JV profit, the operating loss was ₹65.19 crore.

• The ₹344 crore exceptional income in FY25 came from three sources. NCDEX sold 16.01% of its stake in Power Exchange India Limited (PXIL) for ₹15,656 lakhs, generating ₹14,700 lakhs in profit. It additionally remeasured the fair value of its remaining retained 17.06% PXIL stake (now below the 20% associate threshold) at a gain of ₹22,890 lakhs. And it sold its excess 16.22% stake in NERL for ₹2,760 lakhs, generating ₹1,443 lakhs in profit. Net of a ₹1,436 lakh provision for doubtful receivables, total consolidated exceptional income was ₹344 crore.

• Reported consolidated PAT was ₹236.09 crore. EPS basic/diluted was ₹46.86. Total Comprehensive Income was ₹234.69 crore. Every rupee of this profit comes from asset divestments, not operating performance.

• FY26 performance: Revenue from operations grew marginally to ₹90.44 crore (+2.6%), with total income rising to ₹153.37 crore — driven by ₹62.93 crore in other income (investment returns on the ₹770 crore capital raised). Operating losses deepened in absolute terms but narrowed in normalized terms: PAT loss of ₹46.24 crore against core losses of ₹65 crore in FY25. EPS: (₹6.36).

The ₹770 Crore Raise : Who Invested and Why

• In September 2025, following SEBI's July 2025 in-principle approval for NCDEX to launch equity and equity derivatives trading, the exchange completed a preferential allotment of 3,91,12,363 equity shares at ₹197.34 per share, raising ₹770 crore from 61 investors. The allotment was approved by shareholders at the September 1, 2025 EGM.

• The investor roster is a signal of seriousness. Globally, Citadel Securities (Kenneth Griffin's market-making firm) invested ₹17 crore for a 1-2% stake, and Tower Research Capital (one of the world's largest high-frequency trading firms) invested ₹34 crore. These are not passive financial investors: they are firms whose business model is built around providing liquidity to exchanges, and they invest in exchanges where they believe they can generate order flow revenue. Acacia Partners, a US-based investment firm, also participated.

• From India's domestic market: Groww (Billionbrains Garage Ventures) invested ₹50 crore for a 2.82% stake. Zerodha (Rainmatter Capital) invested ₹17 crore for a 0.96% stake. Globe Capital Market invested ₹51 crore. Share India Securities invested ₹28 crore. Kotak Mahindra Life Insurance, JM Financial, and SMC Global Securities also participated.

• From India's celebrated value investor community: Radhakishan Damani (DMart) invested ₹20.26 crore for a 1.41% stake. Ramesh Damani, Madhusudhan Kela, and Sunil Singhania each invested ₹15 crore for a 0.85% stake each. Gopikishan Damani invested ₹9 crore.

• The investment thesis voiced by CEO Arun Raste is direct: NCDEX targeted investors with skin in the game — HFT firms, brokers, and HNIs who are active traders and will benefit economically if the equity launch succeeds. At ₹197.34 per share and current unlisted market price of ₹368, participating investors are already at an 86% unrealised gain.

The Equity Foray: Cash First, Derivatives to Follow

• SEBI granted NCDEX in-principle approval in July 2025 to launch equity and equity derivatives trading. As at May 2026, NCDEX is awaiting SEBI's final approval, with the CEO having indicated expected timeline by end of FY26 (March 2026), with equity cash market launch planned by August 2026. The approach will mirror the MSEI model: cash segment first to establish infrastructure and membership, then derivatives where the real volume potential lies.

• The ₹770 crore is explicitly earmarked for: technology infrastructure for equity operations, risk management systems for clearing, regulatory compliance frameworks for equity market operations, and market development through liquidity incentive programs. In addition, NCDEX has received board approval to launch an electronic mutual fund distribution platform, awaiting regulatory clearance.

• The competitive differentiation argument NCDEX makes is distinct from MSEI's. NCDEX already has: a recognised exchange brand with institutional credibility; an existing membership base across India, particularly in Tier-2 and Tier-3 markets where agri-commodity traders are active; a cleared technology infrastructure; NCCL as a functioning clearing house; and now direct broker-shareholders (Groww, Zerodha) with reason to route equity order flow. The rural penetration through NeML and ReMS creates a distribution and branding moat in markets NSE and BSE have historically under-served.

Balance Sheet: ₹1,720 Crore in Cash and Investments, Zero Financial Debt

• Total consolidated assets as at March 31, 2026, stand at ₹2,003.52 crore. Total equity is ₹1,507.53 crore. Net worth attributable to owners is ₹1,486.92 crore, giving a book value per share of approximately ₹165.77.

• Cash and bank balances total ₹792.36 crore across current and non-current tiers. Financial investments (bonds, mutual funds, corporate FDs) amount to ₹928.18 crore. Together, liquid assets exceed ₹1,720 crore, against near-zero financial debt (only lease liabilities of approximately ₹30.71 crore). This is an exchange that is burning cash in operations but has substantial financial cushion: at the current run-rate of approximately ₹46-₹65 crore annual operating losses, the runway extends well beyond 10 years even without fresh capital. The ₹770 crore raise dramatically extended this runway while funding the equity launch.

KEY RISKS

• Core Business Revenue Is in Structural Decline Due to Commodity Ban : Revenue from operations fell from approximately ₹136 crore (consolidated total income FY24) to ₹122 crore (FY25) to ₹90 crore from operations alone (FY26). The SEBI ban on key commodities, originally a one-year measure from December 2021, has been extended every single year to March 31, 2026. There is no commitment to lift it. If the ban is extended again into FY27, NCDEX's commodity revenue base continues to erode, and the path to operational profitability through commodities alone becomes increasingly distant.

• FY25 Reported Profit Is Entirely Non-Operational : The ₹236.09 crore PAT in FY25 came from ₹344 crore in exceptional income: stake sales in PXIL and NERL. There is no remaining PXIL stake of significance to sell (NCDEX holds 17.06%, below associate threshold). The NERL excess stake was also sold. There is no equivalent exceptional income source visible in FY26 or FY27. Investors anchoring on the FY25 headline profit will be surprised by the FY26 (₹46.24 crore) loss.

• Equity Market Entry Is Uncertain and Structurally Challenging : In-principle SEBI approval for equity trading does not guarantee final approval, does not guarantee member adoption, and does not guarantee liquidity. NCDEX will face the same fundamental liquidity network effect problem as any exchange challenger: equity traders go where equity traders are, and NSE has held 95%-plus derivatives market share for over a decade. Even with Groww and Zerodha as shareholders, routing equity order flow to NCDEX requires member agreements, SEBI compliance, and client consent, none of which is automatic.

• Operating Losses Persist Despite Capital Infusion : The ₹770 crore capital raised in FY26 generated ₹62.93 crore in other income through investment returns, effectively reducing the reported loss. But the core operating cost structure of ₹220 crore against ₹90 crore in operating revenues remains deeply negative. Employee costs alone (₹109.42 crore) exceed revenue from operations (₹90.44 crore). Until the equity launch generates transaction revenue, this structure will not change.

• Citadel and Tower Research Are Market Makers, Not Long-Term Holders : The participation of Citadel Securities and Tower Research is strategically significant, but both firms invest in exchanges where they expect to earn flow revenue. If the equity launch fails to generate adequate volume, these firms have no obligation to remain shareholders. Their exit could signal market disappointment and affect unlisted share pricing.

• No Confirmed IPO Timeline : NCDEX filed a DRHP with SEBI in 2020 which received clarifications and did not proceed. No new DRHP has been filed as of May 2026. The primary exit mechanism for pre-IPO investors remains OTC transactions in the unlisted market. A listing would require NCDEX to demonstrate consistent profitability, which it has not yet achieved on an operational basis.

KEY OPPORTUNITIES

• Commodity Ban Removal Is an Asymmetric Catalyst : The suspended commodities contributed 70% of NCDEX's volumes before the December 2021 ban. If SEBI removes the ban, even partially, the revenue impact is immediate and substantial: reinstating guar, mustard, soya bean, and cotton contracts would restore volumes that have a direct transaction-fee revenue link. At ₹90 crore current operating revenue, restoring even half the banned volumes could double the revenue base in a single year. At that scale, the cost structure of ₹220 crore total expenses reaches operational breakeven. The commodity ban removal is a binary event that existing shareholders have a structural right to benefit from.

• Citadel and Tower Research as Infrastructure for Liquidity : Citadel Securities and Tower Research are collectively responsible for a significant proportion of global exchange liquidity provision. Both firms operate proprietary market-making algorithms across every major equity and derivatives exchange where they are members. Their investment in NCDEX, contingent on the equity launch, means the exchange will have among the world's most sophisticated market makers committed to quoting two-sided prices from day one of equity trading. This is a meaningfully different starting point than MSEI's liquidity journey.

• Groww's 2.82% Stake and 13 Million Active Clients : Groww is India's largest retail broker by active clients, with approximately 13 million accounts. If even a modest fraction of Groww's retail equity order flow is routed to NCDEX's equity cash segment through a dedicated trading connection, the exchange's daily traded value can move from zero to credible volumes quickly. Groww's business economics improve if a competing exchange drives down transaction costs across the industry: shareholder incentives align with routing decisions.

• Agricultural India Is Digitally Underserved — NCDEX Has the Network : NCDEX's commodity exchange operations, NeML's agri e-markets platform, and ReMS's regulated market connections give the exchange direct touchpoints across India's agricultural heartland: Rajasthan's guar belt, Gujarat's cotton market, Maharashtra's oilseed complex, UP's spice markets. As rural India's demat account penetration grows (it is currently the fastest-growing investor demographic), NCDEX has a potential distribution advantage for equity products in markets where NSE and BSE have no physical presence.

• PXIL Retained Stake Optionality : NCDEX still holds 17.06% of Power Exchange India Limited. PXIL is one of two licensed power exchanges in India, operating in a segment experiencing rapid growth as India's renewable energy capacity scales. The retained stake, even below associate threshold, carries embedded value as India's electricity market deepens. Future monetisation represents additional optionality beyond the core exchange business.

• Carbon Credit Market as a Greenfield Opportunity : India's Carbon Credit Trading Scheme is in active development under the government's energy transition agenda. An exchange licensed to trade commodity derivatives is a natural candidate for carbon credit futures and spot market operations. NCDEX, with its commodity market infrastructure, SEBI license, and existing member base in agri and industrial commodity markets, is better positioned than most to apply for and receive a role in India's nascent carbon credit trading ecosystem. This segment does not yet exist at scale but represents a genuinely new revenue category.

Disclaimer : The financial information for the year ended March 31, 2025, is sourced from the official newspaper publication of NCDEX's audited Standalone and Consolidated Financial Results, approved by the Board of Directors on May 23, 2025, and published in Financial Express (all editions) and Navrashtra (Mumbai edition) on May 24, 2025. FY26 financial data is from publicly available MCA filings aggregated by third-party financial data platforms, and has not been directly verified against the company's primary audited annual report. Investors are advised to obtain the audited FY26 annual report directly from the company. The FY25 reported PAT of ₹236.09 crore was entirely driven by ₹344 crore in exceptional income from stake divestments in PXIL and NERL, and does not reflect core operating performance. The company is loss-making on a core operational basis in both FY25 and FY26. The SEBI in-principle approval for equity and equity derivatives trading does not guarantee final approval or a successful equity market launch. No confirmed IPO timeline exists as of May 2026. The ₹770 crore preferential allotment at ₹197.34 per share (September 2025) implies a post-money valuation of approximately ₹1,770 crore: the current unlisted market price of ₹368 per share reflects a premium of approximately 86% above the last institutional allotment price. The current unlisted price range of ₹345 to ₹368 referenced herein is based on publicly available over-the-counter market data (May 26-29, 2026). Investing in NCDEX unlisted shares carries significant risks including but not limited to illiquidity, sustained operating losses, commodity ban extension risk, equity launch execution risk, liquidity network effect challenges, absence of a confirmed IPO timeline, and potential for capital loss. Priveq.in accepts no liability for decisions made in reliance on this content. This content is for informational and educational purposes only and does not constitute investment advice.